Reimagining urinary incontinence
at the source
1 in 2 women live with urinary incontinence; yet fewer than 1 in 3 ever seek treatment. Genevi treats the Urethra, the true cause, not just the symptom.
Get In Touch →Most women give up
and wear pads
One in two women experiences urinary incontinence (78 million in the U.S.) yet only one in three ever raises it with a doctor. Dismissed as just a normal part of aging, women deny it for years and quietly manage with pads, fluid restriction, bathroom mapping, and Kegels.
The treatment path that does exist is cumbersome, with suboptimal results: behavior modification and pelvic-floor training give way to drugs, injections, and surgery, and nearly all of it targets symptoms rather than cause. Most women give up along the way.
The scale of the
unmet need
U.S. women live with urinary incontinence — one in two.
of women with UI report they cannot exercise, laugh, or live without embarrassing leaks.
Only one in three women ever seeks advice from a doctor. Most manage alone, for years.
Urethral closure pressure is 42% lower in women with UI and is the leading predictive indicator of the condition.
Aging leads to a staggering loss of urethral muscle and nerve: up to 65% degradation over a lifetime.
Urinary incontinence is driven by urethral failure. Not pelvic floor support.
The Real Predictor
Urethral closure pressure, not pelvic floor support, is the strongest predictor of incontinence. Women with stress urinary incontinence have maximum urethral closure pressure roughly 42% lower than continent women (Delancey et al., J Urol 2008).
Where It Actually Breaks Down
The urethra itself loses muscle and nerve tissue with age. Roughly 65% of urethral striated muscle fiber is lost over time, alongside a parallel decline in nerve density. That breakdown, not a loss of pelvic support, tracks with the loss of closure pressure (Ashton-Miller & Delancey, 2007)
Why Today's Treatments Miss It
Pelvic floor strength looks nearly identical in continent and incontinent women. Kegels, pelvic floor PT, and slings all target support structures around the urethra, not the urethral muscle itself. Genevi treats the urethra directly.
Learn more about Genevi
For clinicians, partners, and women who want to follow Genevi's progress — start a conversation.
Start a conversation →